AI startups announced about $2.39 billion in primary funding across 14 rounds of $20 million or more between October 6 and October 12, 2026. TypeSafe AI’s $870 million Series A was the largest round, at about 36% of the total.
The largest disclosed AI acquisition was far smaller. Mexican financial group Kapital bought Woz Code, a US startup that makes a cost-cutting plugin for Claude Code, for $30 million.
North American companies raised $1.78 billion across nine rounds, or 74% of the total. Singapore-based Manus made up the whole Asia-Pacific share with more than $500 million, and four European startups raised $111 million.
Two deals need a plain-language note. Healthleap and Melius each announced a seed round and a Series A together, and the table shows the combined sum. No AI venture fund (money a VC firm raises from its own backers to invest later) closed above $20 million this week, and no employee share sale qualified.
AI funding this week: growth and early-stage rounds
The table lists every confirmed AI round of $20 million or more announced in the window, largest first. All amounts were announced in US dollars except WhiteLab Genomics, which reported euros.
| Company | What it does | Round | Amount | Valuation | Lead and notable investors | HQ | Region |
|---|---|---|---|---|---|---|---|
| TypeSafe AI | Builds Jev, a model that returns typed answers such as yes or no, picks and scores for software to use | Series A | US$870M | US$7.5B | Andreessen Horowitz (lead); Sequoia Capital, DCVC | San Francisco, US | North America |
| Manus (Butterfly Effect) | AI agents and app-building tools for consumers and businesses | Not disclosed | More than US$500M | Not disclosed | Boyu Capital, IDG Capital (leads); Tencent, HSG, ZhenFund | Singapore | Asia-Pacific |
| Vinci | AI physics simulation for chip and hardware design | Series B | US$250M | US$1.5B | Advent, Temasek, Xora (co-leads); AMD Ventures, Eclipse, Khosla Ventures, Madrona | Palo Alto, US | North America |
| Arena | Crowdsourced platform that ranks and evaluates AI models | Series B | US$200M | US$3.1B | Lightspeed, Khosla Ventures (co-leads); Salesforce Ventures, Dell Technologies Capital, Andreessen Horowitz, Felicis | California, US | North America |
| Ledgebrook | AI-native specialty insurer for mid-sized businesses | Primary equity (unlabeled) | US$200M | Not disclosed | Allianz X, Rockefeller Capital Management (co-leads) | Boston, US | North America |
| Nous Research | Open-source Hermes agent, with a business version in development | Series B | US$90M | US$1.5B (WSJ report) | Robot Ventures (lead); Nvidia, M12, Samsung, Union Square Ventures, Y Combinator, Menlo Ventures | New York, US | North America |
| Stuut | AI agents that run order-to-cash work such as collections, payments and disputes | Series B | US$52.5M | Not disclosed | Insight Partners (lead); Andreessen Horowitz, M12, Activant | New York, US | North America |
| Sabi | Wearable cap that turns brain signals into text prompts for AI | Seed | US$50M | US$600M (Forbes report) | Khosla Ventures (lead); Accel, DST Global, Initialized, Kevin Weil | Palo Alto, US | North America |
| Hadrian | Agentic AI platform that tests systems the way attackers would | Series B | US$40M | Not disclosed | Forgepoint Capital International, SmartFin (co-leads); HV Capital, Motive Partners, Picus Capital | Amsterdam, Netherlands | Europe/UK |
| Healthleap | AI that reads inpatient records to flag patients with undiagnosed conditions | Seed and Series A | US$38M | Not disclosed | Sequoia Capital, First Round (seed); Hummingbird Ventures (Series A) | San Francisco, US | North America |
| WhiteLab Genomics | AI design of delivery vehicles and payloads for genomic medicines | Series B | €23.2M (about US$26M) | Not disclosed | AVP (lead); Yaday Health, Blast Club, Omnes Capital, Debiopharm | Paris, France | Europe/UK |
| Rivercell | Automated wet lab and AI model that predicts how human cells respond to drugs | Seed | US$25M | Not disclosed | HV (lead); HCVC, Alven, Bpifrance Digital Venture | Paris, France | Europe/UK |
| Melius | Agent platform that produces ad campaigns, images and video | Seed and Series A | US$25M | Not disclosed | CRV (Series A); General Catalyst (seed) | New York, US | North America |
| Vocca | Voice AI that answers patient calls and books appointments for medical practices | Series A | US$20M | Not disclosed | Norrsken VC (lead); Heal Capital, Speedinvest, Firstminute Capital | Paris, France and New York, US | Europe/UK |
AI model and agent developers took most of the money
TypeSafe AI came out of stealth on September 15 with a $40 million seed round led by DCVC, at a post-money valuation of about $200 million. Its Series A arrived less than a month later at $7.5 billion.
The company says about one-third of Fortune 500 firms use Jev and that the model passed one million users within days. TypeSafe has not named those customers, so the figures remain company claims.
Manus closed its first round since Chinese regulators forced Meta to unwind its $2 billion acquisition. The company did not give a valuation, though it was reported in September to be seeking $500 million at $4 billion. Our ownership history of Manus AI covers the buyback that followed the Meta deal.
Nous Research reached about $36 million in annualized revenue by mid-September, according to the Wall Street Journal, and expects to pass $100 million by year-end. The round brings its total funding to about $158 million.
AI evaluation, engineering simulation and new hardware
Arena raised its Series A of $150 million in January at a $1.7 billion valuation, when annualized revenue was $30 million. The company said in June that its run rate had reached $100 million.
Vinci, a 70-person company, told Reuters it will spend the money on computing, hiring and new simulation products. It started with thermal simulation for chips and plans to add vibration and electromagnetics.
Sabi came out of stealth in April. Its first device is a beanie, with a cap version to follow, and the company has not published peer-reviewed accuracy data.
AI applications in insurance, finance and marketing
Ledgebrook’s round brings its total funding to about $315 million, per Crunchbase data. Allianz Re also agreed to a multi-year reinsurance deal with the Boston company.
Stuut raised its Series B 10 months after its Series A, taking total funding to $93 million. Melius said it passed $1 million in annualized revenue within two months of leaving stealth in July.
Healthcare and life sciences AI
Healthleap grew from three hospital partners to more than 50 over the past year, and its revenue rose more than tenfold, the company told TechCrunch. Customers include Penn Medicine and Cedars-Sinai.
Vocca grew from 2,000 to 15,000 medical practitioners in a year. Rivercell, founded in 2025 by Cardiologs co-founder Yann Fleureau, will use its seed money to expand its Paris wet lab.
WhiteLab Genomics has raised about $37 million in total. It tests its AI-designed delivery vehicles in lab and animal studies, and those results are still preclinical.
AI cybersecurity funding
Hadrian’s round brings its total funding to $65 million. The Amsterdam company raised a €10.5 million seed round led by HV Capital in 2022.
AI funds and acquisitions this week
One AI acquisition with a disclosed price met the $20 million threshold. No AI-focused venture fund close above $20 million was confirmed in the window.
| Company | What it does | Round | Amount | Valuation | Lead and notable investors | HQ | Region |
|---|---|---|---|---|---|---|---|
| Woz Code | Maker of WOZCODE, a plugin that the company says cuts Claude Code usage costs by 25% to 55% | Acquisition | US$30M | Not disclosed | Acquirer: Kapital (Mexico) | United States | North America |
Kapital also closed $130 million in combined equity and debt at a $2 billion valuation. The company did not split the two amounts, and the round is not counted here because Kapital is a licensed financial group rather than an AI startup.
AI funding outside the US: regional activity
Europe had four qualifying AI rounds worth $111 million. Three went to Paris-based companies: WhiteLab Genomics, Rivercell and Vocca.
In Asia-Pacific, Manus was the one qualifying deal found. No China-based AI round of $20 million or more with a confirmed announcement date surfaced in the window.
Indian startups raised $122.9 million across 25 deals from October 5 to 9, according to Inc42. The largest AI deal was Desible.ai’s $3.3 million seed, so India had no qualifying AI round.
Latin American startups raised $224.5 million in week 41, Techloy reported, led by Kapital. The other large deals, Asaas and Reuse, were in fintech and refurbished electronics.
Wamda’s coverage of the Middle East showed no AI round of $20 million or more in the window. No weekly African funding roundup for these dates had been published, and searches of African tech outlets found no qualifying AI deal.
For the prior seven days, see last week’s digest on AMD’s World Labs deal, which tracked $2.6 billion across 10 rounds.
FAQ
How much did AI startups raise from October 6 to 12, 2026?
AI startups announced about $2.39 billion across 14 primary rounds of $20 million or more. North American companies raised $1.78 billion of that total, or 74%.
What was the largest AI funding round this week?
TypeSafe AI’s $870 million Series A was the largest. Andreessen Horowitz led it with Sequoia Capital and DCVC, valuing the San Francisco company at $7.5 billion.
What was the biggest AI acquisition this week?
Kapital, a Mexican financial group, bought US-based Woz Code for $30 million. Woz Code makes a plugin that reduces Claude Code usage costs.
Did any Indian AI startup raise over $20 million this week?
No. Inc42 counted $122.9 million across 25 Indian deals from October 5 to 9. The largest AI round was Desible.ai’s $3.3 million seed.
Which investors were most active in AI funding this week?
Khosla Ventures co-led Arena, led Sabi and joined Vinci. Andreessen Horowitz led TypeSafe AI and joined Arena and Stuut. Microsoft’s M12 backed Nous Research and Stuut.
Trends in this week’s AI funding
- AI model and agent developers raised $1.46 billion, or 61% of the week’s total, across TypeSafe AI, Manus and Nous Research. Healthcare and life sciences had the most deals of any sector, with four rounds worth $109 million.
- A few investors appeared in several deals. Khosla Ventures backed three companies, Andreessen Horowitz backed three, and M12 backed two.
- Valuations rose fast. TypeSafe AI went from about $200 million to $7.5 billion in under a month, and Arena moved from $1.7 billion to $3.1 billion in about 10 months.
